Ifosfamide/carboplatin/etoposide (ICE) regimen in small cell lung cancer

This publication has 20 references indexed in Scilit:

• Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide
  Cancer Chemotherapy and Pharmacology, 1990
• A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC)
  British Journal of Cancer, 1989
• The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1988
• Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
  Journal of Clinical Oncology, 1987
• Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer
  Cancer, 1987
• Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
  Journal of Clinical Oncology, 1987
• Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
  European Journal of Cancer and Clinical Oncology, 1987
• Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
  Journal of Clinical Oncology, 1987
• Ifosfamide-pharmacology, safety and therapeutic potential
  Cancer Treatment Reviews, 1985
• Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus
  Cancer Treatment Reviews, 1982